Oakland
Rest Well, Light Sleeper: Saafir, Bay Area Hip-Hop Rapper, Has Died
According to an Instagram post from Xzibit, Bay Area rapper Saafir has died, after reports surfaced that Saafir suffered from health issues.
Twitter Schools Youngster On The Fact MC Hammer Was About That Action
HipHopWired Featured Video CLOSE Source: Kevin.Mazur / Getty Despite the Internet being free and history providing all the necessary lessons, millennial and Gen Z Hip-Hop fans still find ways to question the credentials of certified OGs. One such person is getting a grand lesson that Hammer, also known as MC Hammer, was about that action in those streets despite his dance-friendly music and image. Anthony Duckett of Houston’s Apollo Media team posted a tweet that featured an image of Hammer standing alongside Suge Knight, Snoop Dogg, and the late Tupac “2Pac” Shakur. The tweet caption reads, “I don’t think I’ve ever seen anyone more out of place than Hammer was in this photo lol,” prompting a flurry of “well, actually” responses from those who know the real. Duckett bravely left the tweet ...
E-40 & Too $hort Put The World On Town Bidness In Their Verzuz Battle
Source: Verzuz / Getty Saturday was all about Town Bidness on Saturday night as Verzuz took its breakout streaming platform west to showcase two of the Bay Area’s legendary titans for the final battle of 2020. Too $hort and E-40 took to the Verzuz Ciroc-branded virtual stage that showcased low riders, liquor bottles, and Oakland and Vallejo street signs to big up their oft-times overlooked soil and respective legacies in front of the millions tuned in. Billed as Legends of the Bay, Uncle Earl & $hort Dogg spent more than three hours going back and forth going way past the customary 20 rounds to run through their litany of Bay Area classics. Too Short laced us with old school staples such as ‘Freaky Tales’, Gangsters & Strippers and ‘I’m A Player’ and more contemporary hits like “Sh...
US election: Republicans hold back Democrats, narrowing path to Senate control
The battle for power in the Senate tightened into Wednesday as Democrats picked up a seat in Colorado, but suffered a setback in Alabama, and Republicans held their own in high-profile races in South Carolina, Iowa, Texas and Kansas, dramatically narrowing the political map. Republicans fought to retain their Senate majority by turning back a surge of Democrats challenging allies of President Donald Trump, and the Democrats’ various paths to seizing control were growing more limited. With several contests still too early to call, and one Georgia race heading to a January runoff, the final verdict is expected to drag on. Democrats gained a seat when ex-Gov. John Hickenlooper ousted GOP Sen. Cory Gardner in Colorado, a must-win to flip the Senate, but couldn’t hold on in Alabama, where forme...
Gold rises on renewed US stimulus hope, dollar falls
Spot gold rose 0.3 percent to $1,910.56 an ounce at 3:37pm, New York time, after falling as much as 0.5 percent. Gold rose on renewed optimism for a preelection aid package in the U.S., while the dollar fell to a one-week low. House Speaker Nancy Pelosi said a bill for a compromise stimulus package is being written as she awaits a key phone call with Treasury Secretary Steven Mnuchin. Senate Majority Leader Mitch McConnell said his chamber would take up a comprehensive coronavirus package if an accord is struck. The Bloomberg Dollar Spot Index headed for the third straight decline. Pelosi said in a Bloomberg Television interview that while there are areas where more work is required to get a compromise, she was pleased with the Trump administration’s latest position on coronavirus testing ...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
